GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » 14-Day RSI

Winshine Science Co (HKSE:00209) 14-Day RSI : 48.14 (As of May. 27, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Winshine Science Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-27), Winshine Science Co's 14-Day RSI is 48.14.

The industry rank for Winshine Science Co's 14-Day RSI or its related term are showing as below:

HKSE:00209's 14-Day RSI is ranked worse than
50.93% of 913 companies
in the Travel & Leisure industry
Industry Median: 47.78 vs HKSE:00209: 48.14

Competitive Comparison of Winshine Science Co's 14-Day RSI

For the Leisure subindustry, Winshine Science Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Winshine Science Co's 14-Day RSI Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Winshine Science Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Winshine Science Co's 14-Day RSI falls into.



Winshine Science Co  (HKSE:00209) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Winshine Science Co  (HKSE:00209) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Winshine Science Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Winshine Science Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Winshine Science Co (HKSE:00209) Business Description

Traded in Other Exchanges
N/A
Address
287-299 Queen's Road, Room 1002, 10th Floor, 299 QRC, Central, Hong Kong, HKG
Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.
Executives
Wang Honggang 2101 Beneficial owner
U Credit (hk) Limited 2106 Person having a security interest in shares
Csc Holdings Limited 2106 Person having a security interest in shares
Hurray Talent Investment Development Limited 2101 Beneficial owner
Li Zhonghai 2201 Interest of corporation controlled by you
Liu Lian 2201 Interest of corporation controlled by you
Richsun Investment Development Limited 2101 Beneficial owner
Hong Kong Huiheng Trading And Investment Co., Limited 2101 Beneficial owner
Jiang Qinghui 2201 Interest of corporation controlled by you
Csc Holdings Limited (formerly Known As "china Strategic Holdings Limited") 2106 Person having a security interest in shares
China Strategic Holdings Limited 2106 Person having a security interest in shares
Shen Jia 2101 Beneficial owner

Winshine Science Co (HKSE:00209) Headlines

No Headlines